Peng Li

Title: Peng Li - Innovator in Pharmaceutical Composition

Introduction

Peng Li is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tyrosine kinase inhibitors. His research and inventions have the potential to impact various therapeutic applications.

Latest Patents

Peng Li holds a patent for a tyrosine kinase inhibitor and a pharmaceutical composition comprising the same. This invention relates to a specific structure of the tyrosine kinase inhibitor, which is detailed in the patent documentation. The structures are represented in the formulas (I) and (II), showcasing the unique chemical composition that underpins his invention.

Career Highlights

Peng Li is associated with Guangdong Raynovent Biotech Co., Ltd., where he continues to advance his research in biotechnology and pharmaceuticals. His work is characterized by a commitment to developing effective therapeutic solutions that address critical health challenges.

Collaborations

He collaborates with esteemed colleagues, including Chaofeng Long and Zhengxia Chen, who contribute to the innovative environment at Guangdong Raynovent Biotech Co., Ltd. Their combined expertise fosters a dynamic research atmosphere that enhances the development of new pharmaceutical compositions.

Conclusion

Peng Li's contributions to the field of pharmaceuticals, particularly through his patent on tyrosine kinase inhibitors, highlight his role as an influential inventor. His work not only showcases his innovative spirit but also promises advancements in therapeutic applications.